Company Information

Company Profile

VistaGen Therapeutics (Nasdaq: VTGN) is a clinical-stage biopharmaceutical company committed to developing and commercializing new generation medicines with the potential to go beyond the current standard of care for anxiety, depression and other CNS disorders. Each of VistaGen's CNS drug candidates, PH94B, PH10, and AV-101, has a differentiated mechanism of action, a favorable safety profile in all clinical studies to date, and therapeutic potential in multiple CNS markets.

Contact Information

Investor Relations
Mark Flather
Vice President, Investor Relations
T: +1(650) 577-3617
mflather@vistagen.com

Company Info

Address:
343 Allerton Avenue
South San Francisco, CA 94080

Telephone:
(650) 577-3600

Fax:
(888) 482-2602

Industry Classifications

Sector:
Healthcare

Industry:
Pharmaceuticals

NAICS:
Pharmaceutical Preparation Manufacturing (325412)

SIC:
Pharmaceutical Preparations (2834)